Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to $255.4 million.

  • Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) rose 1.24% to $255.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $255.4 million, marking a year-over-year increase of 1.24%. This contributed to the annual value of $252.5 million for FY2024, which is 0.45% up from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) stood at $255.4 million, which was up 0.28% from $254.7 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) ranged from a high of $257.7 million in Q3 2021 and a low of $250.9 million during Q4 2022.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Shares Outstanding (Weighted Average) value was $251.9 million (recorded in 2024), while the average stood at $252.4 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) dropped by 1.68% in 2022, and later increased by 1.24% in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Shares Outstanding (Weighted Average) (Quarterly) stood at $255.2 million in 2021, then decreased by 1.68% to $250.9 million in 2022, then climbed by 0.21% to $251.4 million in 2023, then rose by 0.45% to $252.5 million in 2024, then increased by 1.24% to $255.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $255.4 million for Q3 2025, versus $254.7 million for Q2 2025 and $254.3 million for Q1 2025.